SAGITTARIUS consortium

SAGITTARIUS is a large and multifaceted clinical trial project. It is being led by a highly multidisciplinary consortium of data scientists, health and social care experts from 5 different European countries - Italy, Belgium, Estonia, Spain, and Germany. The Consortium works alongside a network of highly qualified cancer centres in Italy, Spain and Germany where the SAGITTARIUS approach will be clinically tested.

The Consortium

The consortium behind the SAGITTARIUS project consists of 8 partners carefully selected on the basis of their specific competences and potential contribution to the project objectives.

Partners

IFOM

IFOM - Istituto Fondazione di Oncologia Molecolare Ets, Italy
Design and management and logistics of SAGITTARIUS clinical trial. Overall project management.
➼ Website

Cogentech
COGENTECH srl - Consortium for Genomic Technologies Societa Benefit Srl, Italy
IFOM affiliated partner.
Tumor genetic profiling.
➼ Website
AIRC

AIRC ETS - Fondazione Airc per la ricerca sul cancro Ets, Italy
Stakeholder engagement, communication, and dissemination of materials.
➼ Website

IMIM

Hospital del Mar Research Institute Barcelona, Spain
Clinical trial execution.
➼ Website

Bocconi
Università Commerciale Luigi Bocconi, Italy
Cost-effectiveness analysis.
➼ Website
DiCE
DiCE – Digestive Cancers Europe, Belgium
Stakeholder engagement, communication, and dissemination of materials.
➼ Website
SporeData

Sporedata OU, Estonia
Integrated data analysis.
➼ Website

VHIO
VHIO – Vall d’Hebron Instituto de Oncología, Spain
Clinical trial execution.
➼ Website
Charité
Charité – Universitätsmedizin Berlin, Germany
Clinical trial execution.
➼ Website

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.